Novo Nordisk today announced a new multi-month subscription program for Wegovy (R) (semaglutide) that provides eligible self-pay patients who enroll in the program through select telehealth providers ...

If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...

New 2026 program information covers self-pay pricing tiers, HSA/FSA eligibility, compounded semaglutide and tirzepatide ...

Plasma eMTBR-tau243 also could help identify people with high tau burden ...

Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1Foundayo, Lilly's second FDA-approved obesity ...

Eli Lilly and Company today announced that Foundayotm (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems following the U.S. Food and Drug ...

Ozempic is a GLP-1 prescription medicine that has become popular for weight loss.

Research suggests this sudden, inexplicable condition affects women more than men.

Pregnancy is usually associated with a long list of physical and emotional changes which women face. But studies have shown that in some surprising cases, expectant fathers report experiencing ...

Mainstream medicine consistently fails to explain persistent physical symptoms. So, where is it going wrong? What core ...

The Lone Star tick, which can cause alpha-gal syndrome, is spreading north throughout Massachusetts.

According to neurologist Osman Farooq, who has studied the condition for more than a decade and has published a review of in ...